# Effie Kuti

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/effie-kuti/

## Facts

| Field | Value |
| --- | --- |
| Citations | 519 |
| Field | Diabetes Treatment and Management |
| h-index | 11 |
| i10-index | 11 |
| Last Known Institution | Boehringer Ingelheim (France) |
| OpenAlex ID | https://openalex.org/A5079999072 |
| Works | 38 |

## Researcher papers

- [Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis](https://scholariq.org/papers/impact-of-inappropriate-antibiotic-therapy-on-mortality-in-patients-with/)
- [Burden of hospitalization for heart failure in the United States: a systematic literature review](https://scholariq.org/papers/burden-of-hospitalization-for-heart-failure-in-the-united-states-a-systematic/)
- [Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial](https://scholariq.org/papers/cost-effectiveness-of-empagliflozin-in-patients-with-diabetic-kidney-disease-in/)
- [Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease](https://scholariq.org/papers/differences-in-all-cause-health-care-utilization-and-costs-in-a-type-2-diabetes/)
- [Length of Stay and Hospital Costs Associated with a Pharmacodynamic‐Based Clinical Pathway for Empiric Antibiotic Choice for Ventilator‐Associated Pneumonia](https://scholariq.org/papers/length-of-stay-and-hospital-costs-associated-with-a-pharmacodynamic-based/)
- [Student Measurement of Blood Pressure Using a Simulator Arm Compared with a Live Subject's Arm](https://scholariq.org/papers/student-measurement-of-blood-pressure-using-a-simulator-arm-compared-with-a-live/)
- [The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker](https://scholariq.org/papers/the-development-of-new-onset-type-2-diabetes-associated-with-choosing-a-calcium/)
- [Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both](https://scholariq.org/papers/assessing-risk-of-future-cardiovascular-events-healthcare-resource-utilization/)
- [Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections](https://scholariq.org/papers/pharmacokinetics-antifungal-activity-and-clinical-efficacy-of-anidulafungin-in/)
- [Cardiovascular event incidence and cost in type 2 diabetes mellitus: a Medicare claims-based actuarial analysis](https://scholariq.org/papers/cardiovascular-event-incidence-and-cost-in-type-2-diabetes-mellitus-a-medicare/)
- [Impact of Caring for Individuals With Heart Failure in the United States](https://scholariq.org/papers/impact-of-caring-for-individuals-with-heart-failure-in-the-united-states/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [Boehringer Ingelheim (France)](https://scholariq.org/institutions/boehringer-ingelheim-france/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.